Novo Nordisk has presented new findings from its phase 3 Evoke and Evoke+ trials on using semaglutide as part of Alzheimer’s ...

The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial ...

Avalere Health, a global strategic partner for the healthcare industry, has announced the appointment of Sarah Hall as its ...

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and ...

Pfizer has announced results from its phase 3 BASIS study of Hympavzi (marstacimab), demonstrating its success in reducing ...

Kite, a Gilead Company, has presented new findings demonstrating the safety, efficacy and quality of life benefits offered by ...

Embodiment Perhaps more philosophical, but none-the less highly relevant, is the concept of embodiment – the experience of ...

New results from the phase 1 VNA-318-01 human study have shown favourable safety and tolerability, with the data showing that ...

As global pricing reforms squeeze margins and reshapes supply chains, manufacturers can restore confidence through smarter ...

Eisai has submitted a new drug application to Japan’s Pharmaceuticals and Medical Devices Agency for a subcutaneous ...

The agreement states that the UK will pay more for medicines through the NHS, in exchange for an agreement that US import ...

AI-generated personas can assist in brainstorming with a hypothetical HCP, validate test queries for medical information ...